Insider Trading & Ownership - TYLE PRAVEEN

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for TYLE PRAVEEN

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-29
Option Award
2024-03-04
06:20 am
N/A
2034-03-01
Skye Bioscience Inc.SKYETYLE PRAVEEN
Director
35,000$035,000
(Direct)
View
2023-11-06
Option Award
2023-11-06
8:29 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYETYLE PRAVEEN
Director
14,110$020,001
(Direct)
View
2023-09-29
Option Award
2023-10-03
4:46 pm
N/A
2033-09-29
KIORA PHARMACEUTICALS INCKPRXTYLE PRAVEEN
Director
5,000$05,000
(Direct)
View
2023-08-25
Option Award
2023-08-29
6:22 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYETYLE PRAVEEN
Director
1,472,692$01,472,692
(Direct)
View
2023-03-03
Option Award
2023-03-07
8:14 pm
N/A
2033-03-03
KIORA PHARMACEUTICALS INCKPRXTYLE PRAVEEN
Director
8,000$08,000
(Direct)
View
2023-01-05
Option Award(A)
2023-01-09
11:28 am
N/A
2033-01-05
Skye Bioscience Inc.SKYETYLE PRAVEEN
Director
250,000$0250,000
(Direct)
View
2023-01-05
Option Award
2023-01-06
5:21 pm
N/A
2033-01-05
Skye Bioscience Inc.SKYETYLE PRAVEEN
Director
250,000$0250,000
(Direct)
View
2022-02-01
Option Award
2022-02-03
7:06 pm
N/A
2032-02-01
KIORA PHARMACEUTICALS INCKPRXTYLE PRAVEEN
Director
5,000$05,000
(Direct)
View
2021-09-14
Option Award
2021-09-16
4:01 pm
N/A
2031-09-14
Skye Bioscience Inc.SKYETYLE PRAVEEN
Director
25,000$0275,000
(Direct)
View
2021-07-22
Option Award
2021-07-26
2:23 pm
N/A
2031-07-22
Skye Bioscience Inc.SKYETYLE PRAVEEN
Director
250,000$0250,000
(Direct)
View
2021-02-28
Tax Withholding
2021-03-02
5:00 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXTYLE PRAVEEN
EVP, R&D
16,560$7.19204,771
(Direct)
View
2021-02-28
Exercise
2021-03-02
5:00 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXTYLE PRAVEEN
EVP, R&D
68,007$0204,771
(Direct)
View
2021-02-11
Option Award
2021-02-16
4:41 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXTYLE PRAVEEN
EVP, R&D
128,410$0128,410
(Direct)
View
2021-02-01
Option Award
2021-02-03
9:53 pm
N/A
2031-02-01
EYEGATE PHARMACEUTICALS INCEYEGTYLE PRAVEEN
Director
3,333$03,333
(Direct)
View
2020-04-22
Option Award
2020-04-24
5:20 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXTYLE PRAVEEN
EVP, R&D
19,893$069,344
(Direct)
View
2020-04-22
Tax Withholding
2020-04-24
5:20 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXTYLE PRAVEEN
EVP, R&D
4,844$1.9669,344
(Direct)
View
2020-02-28
Exercise
2020-03-03
4:17 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXTYLE PRAVEEN
EVP, R&D
39,316$0120,212
(Direct)
View
2020-02-14
Option Award
2020-02-19
4:32 pm
N/A
2030-02-14
EYEGATE PHARMACEUTICALS INCEYEGTYLE PRAVEEN
Director
3,333$03,333
(Direct)
View
2020-02-06
Option Award
2020-02-10
4:14 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXTYLE PRAVEEN
EVP, R&D
344,280$0344,280
(Direct)
View
(A) Indicate amendment filing.